Unattributed Code Systems

• https://gravitatehealth.eu/section
• https://spor.ema.europa.eu/v1/lists/100000000002/terms/
• https://spor.ema.europa.eu/v1/lists/100000072049/terms/
• https://spor.ema.europa.eu/v1/lists/100000155531/terms/
• https://spor.ema.europa.eu/v1/lists/200000029659/terms/
• https://spor.ema.europa.eu/v1/lists/220000000060/terms/

Copyright Fragment

This fragment is available on credits.html

Copyright and Registered Trademark Uses

• IG © 2023+ Nordic Health Information Partnership. Package nordic-epi-ig#0.1.0 based on FHIR 5.0.0. Generated 2025-08-27 Links: Table of Contents | QA Report This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 945334.The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Datapharm Limited. a EU funded project Innovative Medicines Initiative (IMI) European Federation of Pharmaceutical Industries and Associations Datapharm ( src )
• hl7.fhir.us.hai: Healthcare Associated Infection Implementation Guide ®© HL7 | CC0 ( src )
• Nordic ePI IG, published by Nordic Health Information Partnership. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/felleskatalogen/nordic-epi-ig/ and changes regularly. See the Directory of published versions ( src )

External References

Type	Reference	Content
web	www.gravitatehealth.eu
web	github.com	Nordic ePI IG, published by Nordic Health Information Partnership. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/felleskatalogen/nordic-epi-ig/ and changes regularly. See the Directory of published versions
web	www.imi.europa.eu
web	www.efpia.eu
web	www.datapharm.com
web	www.legemiddelverket.no	Kontakt lege, apotek eller sykepleier dersom du opplever bivirkninger. Dette gjelder også bivirkninger som ikke er nevnt i pakningsvedlegget. Du kan også melde fra om bivirkninger direkte via meldeskjema som finnes på nettsiden til Statens legemiddelverk: www.legemiddelverket.no/pasientmelding . Ved å melde fra om bivirkninger bidrar du med informasjon om sikkerheten ved bruk av dette legemidlet.
web	spor.ema.europa.eu	Codes from EMA's SPOR RMS are used whenever possible to identify sections. These codes are defined as a FHIR code system in Quality Review of Documents Product Information Template as part of this implementation guide to facilitate validation of the example resources.
web	spor.ema.europa.eu	The profiles follow applicable conventions from EMA's ePI project and the code systems give preference to codes defined in SPOR RMS . Profiling and the creation of examples is informed by FHIR ePIs exported from EMA's PLM Portal and IDMP implementation guide .
web	plm-portal.ema.europa.eu	The profiles follow applicable conventions from EMA's ePI project and the code systems give preference to codes defined in SPOR RMS . Profiling and the creation of examples is informed by FHIR ePIs exported from EMA's PLM Portal and IDMP implementation guide .
web	www.ema.europa.eu	The profiles follow applicable conventions from EMA's ePI project and the code systems give preference to codes defined in SPOR RMS . Profiling and the creation of examples is informed by FHIR ePIs exported from EMA's PLM Portal and IDMP implementation guide .
web	www.ema.europa.eu	In the Nordic countries, the structure of package leaflets follows the QRD template from EMA .
web	fimea.fi	Finland: Lääkevalmiste ( Basic register )
web	www.dmp.no	Norway: LegemiddelMerkevare ( FEST (Forskrivnings- og ekspedisjonsstøtte) )
web	www.lakemedelsverket.se	Sweden: medprod.nplid ( NPL (Nationellt produktregister för läkemedel, NPL) )

Internal Images

bundle-components.png

tree-filter.png